CHINA HEALTH (00673) announced its interim results for the six months ended September 20, 2025. The company reported revenue of HK$19.61 million, marking a 4.98% year-on-year increase. Shareholder losses attributable to owners narrowed by approximately 40.40% to HK$10.363 million compared to the same period last year. Basic loss per share stood at HK2.11 cents.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.